BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16259061)

  • 21. Intubating conditions after three different doses of rocuronium in the elderly.
    Bunburaphong P; Werawatganon T; Panyarachun K; Vimala J; Chainongbua J; Tungamornsatit J
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S244-50. PubMed ID: 11529339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rocuronium for rapid sequence induction in morbidly obese patients: a prospective study for evaluation of intubation conditions after administration 1.2 mg kg⁻¹ ideal body weight of rocuronium.
    Gaszynski TM; Szewczyk T
    Eur J Anaesthesiol; 2011 Aug; 28(8):609-10. PubMed ID: 21562423
    [No Abstract]   [Full Text] [Related]  

  • 23. Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS
    Anesth Analg; 1996 Nov; 83(5):1076-80. PubMed ID: 8895289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking does not alter the dose-requirements and the pharmacodynamics of rocuronium.
    Pühringer FK; Keller P; Löckinger A; Kleinsasser A; Scheller A; Raedler C; Keller C
    Can J Anaesth; 2000 Apr; 47(4):347-9. PubMed ID: 10764181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
    Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
    Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
    Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
    Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intubating conditions after three different doses of rocuronium.
    Somboonviboon W; Bunburaphong P; Whanna O; Juajarungjai S; Sukvivat K
    J Med Assoc Thai; 2000 Aug; 83(8):850-5. PubMed ID: 10998836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised controlled trial comparing rocuronium priming, magnesium pre-treatment and a combination of the two methods.
    Kim MH; Oh AY; Jeon YT; Hwang JW; Do SH
    Anaesthesia; 2012 Jul; 67(7):748-54. PubMed ID: 22420830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rocuronium bromide in the ICU: dose finding and pharmacokinetics.
    Khuenl-Brady KS; Sparr H; Pühringer F; Agoston S
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():79-80. PubMed ID: 8557012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
    Whalley DG; Maurer WG; Knapik AL; Estafanous FG
    Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the influence of desflurane nitrous oxide anesthesia to propofol nitrous oxide anesthesia on rocuronium bromide induced neuromuscular block.
    Verhaeghe B; Vanacker B; Van de Velde M; Vandermeersch E
    Acta Anaesthesiol Belg; 2001; 52(3):301-5. PubMed ID: 11732388
    [No Abstract]   [Full Text] [Related]  

  • 33. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
    Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
    Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking increases the requirement for rocuronium.
    Rautoma P; Svartling N
    Can J Anaesth; 1998 Jul; 45(7):651-4. PubMed ID: 9717597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potency and recovery characteristics of rocuronium mixed with sodium bicarbonate.
    Lee HJ; Kim KS; Yeon JT; Suh JK; Sung IH; Shin IC
    Anaesthesia; 2010 Sep; 65(9):899-903. PubMed ID: 20608923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacodynamic effects of rocuronium during general anesthesia in patients with type 2 diabetes mellitus.
    Alper I; Ulukaya S; Makay O; Balcioglu T
    Minerva Anestesiol; 2010 Feb; 76(2):115-9. PubMed ID: 20150852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.